India Favipiravir market is
projected to show a robust growth in the forecast period, FY2023 - FY2027, with
an impressive CAGR, on account of rising demand for effective and efficient
drugs and therapeutics for the viral infection like COVID-19. The drug is being
manufactured and marketed in large scale for its effectiveness in controlling mild
to moderate COVID-19 infection. Moreover, the drug is also effective in the
treatment of viral infections from Ebola virus and Influenza A & B viruses.
All these advantages of Favipiravir has led to an increase in the growth of the India Favipiravir market. Also,
after the approval to new market players like Lupin, and Vivimed Ltd. the
market growth is anticipated to boost in the next five years. With consistent
technological advancement and governmental support towards the extensive
research and development of the efficient drugs, the market is expected to
register its exponential CAGR growth in the upcoming five years. Although,
rapidly emerging drugs from the export pathway may put a minor restraint on the
market growth in the upcoming five years.
The India Favipiravir market
is segmented on the basis of route of administration, dosage form, distribution
channel, application, source, regional distribution, and competitional
landscape. Based on route of administration, the market is further bifurcated
into oral and intravenous administrations. Intravenous administrations are the
method of injecting the drug in a solution form in the veins of the patient.
The method is anticipated to be more effective over oral administrations of any
drug. Oral administrations involve intake of tablets. The Favipiravir drug is widely
available in the tablet form in the Indian market. Major market players like
Vivimed ltd. have received authority from the director general of health
services in India to manufacture and market the Favipiravir tablets with the
name, ‘Favulous’ of 200mg and 400mg strength. With the unexpected jump in the
number of patients suffering from COVID-19, the market is experiencing a surge
in the demand for more and effective treatment options.
Holding the largest shares of
the India Favipiravir market, a partial list of the established market players
includes Cipla Ltd., Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals
Industries Ltd., Zendara Pharma Ltd., Indoco Remedies Ltd., Curequest
Lifescience India Pvt. Ltd., Gonane Pharma Ltd., Lee Pharma Ltd., Hetero Labs
Pvt. Ltd., Dr. Reddy’s Laboratories Ltd, among others. The pharmaceutical
companies are in close contact with the research and development institutes
that are consistently developing the better and efficient therapeutics and
drugs like Favipiravir to overcome the impact of the pandemic. Technological
advancement and advanced research techniques are being implemented and
pharmaceutical companies are making sure that they have the approval from the
governmental authorities to manufacture and market the drugs and the
therapeutics on a larger scale.
Years considered
for this report:
Historical Years: FY2017 – FY2020
Base Year: FY2021
Estimated Year: FY2022E
Forecast Period: FY2023F – FY2027F
Objective of the Study:
o
To analyze
the historical growth in the market size of India Favipiravir market from FY2017
to FY2021.
o
To
estimate and forecast the market size of India Favipiravir market from FY2022
to FY2027 and growth rate until FY2027.
o
To
classify and forecast India Favipiravir market based on route
of administration, dosage form, distribution channel, application, source,
competitional landscape, and regional distribution.
o To identify dominant region or segment
in the India Favipiravir market.
o
To
identify drivers and challenges for India Favipiravir market.
o
To
examine competitive developments such as expansions, new product launches,
mergers & acquisitions, etc., in India Favipiravir market.
o
To
identify and analyze the profile of leading players operating in
India Favipiravir market.
o To identify key sustainable strategies
adopted by market players in India Favipiravir market.
Click here to download the sample
TechSci Research performed both primary
as well as exhaustive secondary research for this study. Initially, TechSci
Research sourced a list of manufacturers, suppliers, across the country.
Subsequently, TechSci Research conducted primary research surveys with the
identified companies. While interviewing, the respondents were also enquired
about their competitors. Through this technique, TechSci Research could include
the manufactures which could not be identified due to the limitations of
secondary research. TechSci Research analyzed the manufactures, distribution
channels and presence of all major players across the country.
TechSci Research calculated the market
size of India Favipiravir
market using a bottom-up
approach, wherein data for various end-user segments was recorded and forecast
for the future years. TechSci Research sourced these values from the industry
experts and company representatives and externally validated through analyzing
historical data of these product types and applications for getting an
appropriate, overall market size. Various secondary sources such as company
websites, news articles, press releases, company annual reports, investor
presentations and financial reports were also studied by TechSci Research.
Key
Target Audience:
o Favipiravir manufacturers, end
users, and other stakeholders
o Distributers and suppliers of Favipiravir
and other stakeholders
o Organizations, forums and
alliances related to Favipiravir
o Market research and consulting
firms
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers, end users, etc., besides allowing them in
strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, India Favipiravir market has been segmented into
following categories, in addition to the industry trends which have also been
detailed below:
- India Favipiravir Market, By Route of Administration:
- India Favipiravir Market, By Dosage
Form:
o Tablet
o Capsule
- India Favipiravir Market, By
Application:
- Influenza A&B
- Ebola
- COVID-19
- India Favipiravir Market, By
Source:
- Contract Manufacturing
Organizations
- In-House
- India Favipiravir Market, By
Distribution Channel:
- Hospitals
- Clinics
- Drug Stores/ Pharmacies
- Online
- Others
- India Favipiravir Market, By
Region:
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in India Favipiravir market.
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
o Detailed analysis and profiling of
additional market players (up to five).
India Favipiravir Market is
an upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]